Merck galloped 11.5% to hit a new high on the back of strong Q4 results. The Company’s revenue and EPS grew 25.8% and 53% y/y, respectively. The stock is currently trading 25% above its pivot price of Rs 1,686.80.
Merck galloped 11.5% to hit a new high on the back of strong Q4 results. The Company’s revenue and EPS grew 25.8% and 53% y/y, respectively. The stock is currently trading 25% above its pivot price of Rs 1,686.80.